Title:
PYRAZINE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2015/174417
Kind Code:
A1
Abstract:
The present invention relates to: a novel pyrazine derivative that is represented by formula (I) and is useful as a therapeutic agent or preventive agent for diseases involving URAT1, such as gout, hyperuricemia, hypertension, kidney diseases such as interstitial nephritis, diabetes, arteriosclerosis, or Lesch-Nyhan syndrome; or a pharmaceutically acceptable salt of said derivative; or a solvate of said derivative or salt. (The symbols in the formula are as defined in the description.)
Inventors:
MARUYAMA AKINOBU (JP)
TAKEUCHI SUSUMU (JP)
TAKAHASHI YOSHIMASA (JP)
TAKEUCHI SUSUMU (JP)
TAKAHASHI YOSHIMASA (JP)
Application Number:
PCT/JP2015/063654
Publication Date:
November 19, 2015
Filing Date:
May 12, 2015
Export Citation:
Assignee:
TEIJIN PHARMA LTD (JP)
International Classes:
C07D403/04; A61K31/497; A61P3/10; A61P9/10; A61P9/12; A61P13/12; A61P19/06; A61P43/00; C07D401/14; C07D403/14; C07D409/14
Domestic Patent References:
| WO2008126899A1 | 2008-10-23 | |||
| WO2014077285A1 | 2014-05-22 |
Foreign References:
| JP2013528655A | 2013-07-11 | |||
| JP2006036792A | 2006-02-09 | |||
| JP2007145786A | 2007-06-14 |
Other References:
See also references of EP 3144306A4
Attorney, Agent or Firm:
AOKI, Atsushi et al. (JP)
Aoki 篤 (JP)
Aoki 篤 (JP)
Download PDF:
Previous Patent: SUPERCONDUCTING MAGNET
Next Patent: TERMINAL DEVICE, SERVER DEVICE, AND COMMUNICATION CONTROL METHOD
Next Patent: TERMINAL DEVICE, SERVER DEVICE, AND COMMUNICATION CONTROL METHOD